These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


447 related items for PubMed ID: 29196101

  • 1. miR-135b-5p Promotes migration, invasion and EMT of pancreatic cancer cells by targeting NR3C2.
    Zhang Z, Che X, Yang N, Bai Z, Wu Y, Zhao L, Pei H.
    Biomed Pharmacother; 2017 Dec; 96():1341-1348. PubMed ID: 29196101
    [Abstract] [Full Text] [Related]

  • 2. miR-196a-5p promotes metastasis of colorectal cancer via targeting IκBα.
    Xin H, Wang C, Liu Z.
    BMC Cancer; 2019 Jan 08; 19(1):30. PubMed ID: 30621631
    [Abstract] [Full Text] [Related]

  • 3. Long non-coding RNA linc00673 regulated non-small cell lung cancer proliferation, migration, invasion and epithelial mesenchymal transition by sponging miR-150-5p.
    Lu W, Zhang H, Niu Y, Wu Y, Sun W, Li H, Kong J, Ding K, Shen HM, Wu H, Xia D, Wu Y.
    Mol Cancer; 2017 Jul 11; 16(1):118. PubMed ID: 28697764
    [Abstract] [Full Text] [Related]

  • 4. Targeting the Notch1 oncogene by miR-139-5p inhibits glioma metastasis and epithelial-mesenchymal transition (EMT).
    Li J, Li Q, Lin L, Wang R, Chen L, Du W, Jiang C, Li R.
    BMC Neurol; 2018 Aug 31; 18(1):133. PubMed ID: 30170559
    [Abstract] [Full Text] [Related]

  • 5. MiR-30c-5p suppresses migration, invasion and epithelial to mesenchymal transition of gastric cancer via targeting MTA1.
    Cao JM, Li GZ, Han M, Xu HL, Huang KM.
    Biomed Pharmacother; 2017 Sep 31; 93():554-560. PubMed ID: 28686969
    [Abstract] [Full Text] [Related]

  • 6. Role of exosomal microRNA-125b-5p in conferring the metastatic phenotype among pancreatic cancer cells with different potential of metastasis.
    Wu M, Tan X, Liu P, Yang Y, Huang Y, Liu X, Meng X, Yu B, Wu Y, Jin H.
    Life Sci; 2020 Aug 15; 255():117857. PubMed ID: 32470446
    [Abstract] [Full Text] [Related]

  • 7. MiR-873-5p inhibits cell migration, invasion and epithelial-mesenchymal transition in colorectal cancer via targeting ZEB1.
    Li G, Xu Y, Wang S, Yan W, Zhao Q, Guo J.
    Pathol Res Pract; 2019 Jan 15; 215(1):34-39. PubMed ID: 30455125
    [Abstract] [Full Text] [Related]

  • 8. MiR-155-5p promotes oral cancer progression by targeting chromatin remodeling gene ARID2.
    Wu M, Duan Q, Liu X, Zhang P, Fu Y, Zhang Z, Liu L, Cheng J, Jiang H.
    Biomed Pharmacother; 2020 Feb 15; 122():109696. PubMed ID: 31918270
    [Abstract] [Full Text] [Related]

  • 9. MicroRNA-198-5p inhibits the migration and invasion of non-small lung cancer cells by targeting fucosyltransferase 8.
    Wang S, Zhang X, Yang C, Xu S.
    Clin Exp Pharmacol Physiol; 2019 Oct 15; 46(10):955-967. PubMed ID: 31381176
    [Abstract] [Full Text] [Related]

  • 10. FAM83A-AS1 promotes lung adenocarcinoma cell migration and invasion by targeting miR-150-5p and modifying MMP14.
    Xiao G, Wang P, Zheng X, Liu D, Sun X.
    Cell Cycle; 2019 Nov 15; 18(21):2972-2985. PubMed ID: 31522616
    [Abstract] [Full Text] [Related]

  • 11. MicroRNA-296-5p inhibits cell metastasis and invasion in nasopharyngeal carcinoma by reversing transforming growth factor-β-induced epithelial-mesenchymal transition.
    Chen M, Chen C, Luo H, Ren J, Dai Q, Hu W, Zhou K, Tang X, Li X.
    Cell Mol Biol Lett; 2020 Nov 03; 25(1):49. PubMed ID: 33292168
    [Abstract] [Full Text] [Related]

  • 12. LncRNA UCA1 sponges miR-204-5p to promote migration, invasion and epithelial-mesenchymal transition of glioma cells via upregulation of ZEB1.
    Liang C, Yang Y, Guan J, Lv T, Qu S, Fu Q, Zhao H.
    Pathol Res Pract; 2018 Sep 03; 214(9):1474-1481. PubMed ID: 30107990
    [Abstract] [Full Text] [Related]

  • 13. Role of miR-214-5p in the migration and invasion of pancreatic cancer cells.
    Cao TH, Ling X, Chen C, Tang W, Hu DM, Yin GJ.
    Eur Rev Med Pharmacol Sci; 2018 Nov 03; 22(21):7214-7221. PubMed ID: 30468464
    [Abstract] [Full Text] [Related]

  • 14. MicroRNA-374c-5p regulates the invasion and migration of cervical cancer by acting on the Foxc1/snail pathway.
    Huang Y, Huang H, Li M, Zhang X, Liu Y, Wang Y.
    Biomed Pharmacother; 2017 Oct 03; 94():1038-1047. PubMed ID: 28810526
    [Abstract] [Full Text] [Related]

  • 15. miR-139-5p inhibits epithelial-mesenchymal transition, migration and invasion of hepatocellular carcinoma cells by targeting ZEB1 and ZEB2.
    Qiu G, Lin Y, Zhang H, Wu D.
    Biochem Biophys Res Commun; 2015 Jul 31; 463(3):315-21. PubMed ID: 26022123
    [Abstract] [Full Text] [Related]

  • 16. MicroRNA-135b regulates metastasis suppressor 1 expression and promotes migration and invasion in colorectal cancer.
    Wu W, Wang Z, Yang P, Yang J, Liang J, Chen Y, Wang H, Wei G, Ye S, Zhou Y.
    Mol Cell Biochem; 2014 Mar 31; 388(1-2):249-59. PubMed ID: 24343340
    [Abstract] [Full Text] [Related]

  • 17. miR-381 inhibited breast cancer cells proliferation, epithelial-to-mesenchymal transition and metastasis by targeting CXCR4.
    Xue Y, Xu W, Zhao W, Wang W, Zhang D, Wu P.
    Biomed Pharmacother; 2017 Feb 31; 86():426-433. PubMed ID: 28012397
    [Abstract] [Full Text] [Related]

  • 18. sMicroRNA-28-5p acts as a metastasis suppressor in gastric cancer by targeting Nrf2.
    Yue CF, Li LS, Ai L, Deng JK, Guo YM.
    Exp Cell Res; 2021 May 15; 402(2):112553. PubMed ID: 33737068
    [Abstract] [Full Text] [Related]

  • 19. Protein tyrosine phosphatase non-receptor type 12 (PTPN12), negatively regulated by miR-106a-5p, suppresses the progression of hepatocellular carcinoma.
    Liang Z, Li X, Duan F, Song L, Wang Z, Li X, Yang P, Li L.
    Hum Cell; 2022 Jan 15; 35(1):299-309. PubMed ID: 34784010
    [Abstract] [Full Text] [Related]

  • 20. miR 1296-5p Inhibits the Migration and Invasion of Gastric Cancer Cells by Repressing ERBB2 Expression.
    Shan X, Wen W, Zhu D, Yan T, Cheng W, Huang Z, Zhang L, Zhang H, Wang T, Zhu W, Zhu Y, Zhu J.
    PLoS One; 2017 Jan 15; 12(1):e0170298. PubMed ID: 28099468
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 23.